Loading...

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment

Targeting the immune checkpoint receptors cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed cell death 1 ligand 1 (PD-L1) represents a very attractive treatment modality for tumor patients. The administration of antibodies against these receptors can pr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biomedicines
Main Authors: Tunger, Antje, Kießler, Maximilian, Wehner, Rebekka, Temme, Achim, Meier, Friedegund, Bachmann, Michael, Schmitz, Marc
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5874683/
https://ncbi.nlm.nih.gov/pubmed/29494517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines6010026
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!